Literature DB >> 24616037

Mechanisms of chromosomal instability in melanoma.

William K Kaufmann1, Craig C Carson, Bernard Omolo, Adam J Filgo, Maria J Sambade, Dennis A Simpson, Janiel M Shields, Joseph G Ibrahim, Nancy E Thomas.   

Abstract

A systems biology approach was applied to investigate the mechanisms of chromosomal instability in melanoma cell lines. Chromosomal instability was quantified using array comparative genomic hybridization to identify somatic copy number alterations (deletions and duplications). Primary human melanocytes displayed an average of 8.5 alterations per cell primarily representing known polymorphisms. Melanoma cell lines displayed 25 to 131 alterations per cell, with an average of 68, indicative of chromosomal instability. Copy number alterations included approximately equal numbers of deletions and duplications with greater numbers of hemizygous (-1,+1) alterations than homozygous (-2,+2). Melanoma oncogenes, such as BRAF and MITF, and tumor suppressor genes, such as CDKN2A/B and PTEN, were included in these alterations. Duplications and deletions were functional as there were significant correlations between DNA copy number and mRNA expression for these genes. Spectral karyotype analysis of three lines confirmed extensive chromosomal instability with polyploidy, aneuploidy, deletions, duplications, and chromosome rearrangements. Bioinformatic analysis identified a signature of gene expression that was correlated with chromosomal instability but this signature provided no clues to the mechanisms of instability. The signature failed to generate a significant (P = 0.105) prediction of melanoma progression in a separate dataset. Chromosomal instability was not correlated with elements of DNA damage response (DDR) such as radiosensitivity, nucleotide excision repair, expression of the DDR biomarkers γH2AX and P-CHEK2, nor G1 or G2 checkpoint function. Chromosomal instability in melanoma cell lines appears to influence gene function but it is not simply explained by alterations in the system of DDR.
Copyright © 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  DNA damage response; checkpoint; genetic instability; melanoma; prognosis; repair

Mesh:

Year:  2014        PMID: 24616037      PMCID: PMC4128338          DOI: 10.1002/em.21859

Source DB:  PubMed          Journal:  Environ Mol Mutagen        ISSN: 0893-6692            Impact factor:   3.216


  69 in total

1.  Similar nucleotide excision repair capacity in melanocytes and melanoma cells.

Authors:  Shobhan Gaddameedhi; Michael G Kemp; Joyce T Reardon; Janiel M Shields; Stephanie L Smith-Roe; William K Kaufmann; Aziz Sancar
Journal:  Cancer Res       Date:  2010-05-25       Impact factor: 12.701

Review 2.  Early detection and treatment of skin cancer.

Authors:  A F Jerant; J T Johnson; C D Sheridan; T J Caffrey
Journal:  Am Fam Physician       Date:  2000-07-15       Impact factor: 3.292

3.  Analysis of G(1)/S checkpoint regulators in metastatic melanoma.

Authors:  I Sauroja; J Smeds; T Vlaykova; R Kumar; L Talve; M Hahka-Kemppinen; K Punnonen; C T Jansèn; K Hemminki; S Pyrhönen
Journal:  Genes Chromosomes Cancer       Date:  2000-08       Impact factor: 5.006

4.  Identification of TFG (TRK-fused gene) as a putative metastatic melanoma tumor suppressor gene.

Authors:  Ken Dutton-Regester; Lauren G Aoude; Derek J Nancarrow; Mitchell S Stark; Linda O'Connor; Cathy Lanagan; Gulietta M Pupo; Varsha Tembe; Candace D Carter; Michael O'Rourke; Richard A Scolyer; Graham J Mann; Christopher W Schmidt; Adrian Herington; Nicholas K Hayward
Journal:  Genes Chromosomes Cancer       Date:  2012-01-17       Impact factor: 5.006

5.  The role of BRAF mutation and p53 inactivation during transformation of a subpopulation of primary human melanocytes.

Authors:  Hong Yu; Ronan McDaid; John Lee; Patricia Possik; Ling Li; Suresh M Kumar; David E Elder; Patricia Van Belle; Phyllis Gimotty; Matt Guerra; Rachel Hammond; Katharine L Nathanson; Maria Dalla Palma; Meenhard Herlyn; Xiaowei Xu
Journal:  Am J Pathol       Date:  2009-04-23       Impact factor: 4.307

6.  High expression of DNA repair pathways is associated with metastasis in melanoma patients.

Authors:  A Kauffmann; F Rosselli; V Lazar; V Winnepenninckx; A Mansuet-Lupo; P Dessen; J J van den Oord; A Spatz; A Sarasin
Journal:  Oncogene       Date:  2007-09-24       Impact factor: 9.867

7.  Defective cell cycle checkpoint functions in melanoma are associated with altered patterns of gene expression.

Authors:  William K Kaufmann; Kathleen R Nevis; Pingping Qu; Joseph G Ibrahim; Tong Zhou; Yingchun Zhou; Dennis A Simpson; Jennifer Helms-Deaton; Marila Cordeiro-Stone; Dominic T Moore; Nancy E Thomas; Honglin Hao; Zhi Liu; Janiel M Shields; Glynis A Scott; Norman E Sharpless
Journal:  J Invest Dermatol       Date:  2007-06-28       Impact factor: 8.551

8.  The role of sunlight and DNA repair in melanoma and nonmelanoma skin cancer. The xeroderma pigmentosum paradigm.

Authors:  K H Kraemer; M M Lee; A D Andrews; W C Lambert
Journal:  Arch Dermatol       Date:  1994-08

9.  Number of nevi and early-life ambient UV exposure are associated with BRAF-mutant melanoma.

Authors:  Nancy E Thomas; Sharon N Edmiston; Audrey Alexander; Robert C Millikan; Pamela A Groben; Honglin Hao; Dawn Tolbert; Marianne Berwick; Klaus Busam; Colin B Begg; Dianne Mattingly; David W Ollila; Chiu Kit Tse; Amanda Hummer; Julia Lee-Taylor; Kathleen Conway
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2007-05       Impact factor: 4.254

10.  Oncogene-induced telomere dysfunction enforces cellular senescence in human cancer precursor lesions.

Authors:  Anitha Suram; Jessica Kaplunov; Priyanka L Patel; Haihe Ruan; Aurora Cerutti; Virginia Boccardi; Marzia Fumagalli; Raffaella Di Micco; Neena Mirani; Resham Lal Gurung; Manoor Prakash Hande; Fabrizio d'Adda di Fagagna; Utz Herbig
Journal:  EMBO J       Date:  2012-05-08       Impact factor: 11.598

View more
  8 in total

1.  Effective intra-S checkpoint responses to UVC in primary human melanocytes and melanoma cell lines.

Authors:  Marila Cordeiro-Stone; John J McNulty; Christopher D Sproul; Paul D Chastain; Eugene Gibbs-Flournoy; Yingchun Zhou; Craig Carson; Shangbang Rao; David L Mitchell; Dennis A Simpson; Nancy E Thomas; Joseph G Ibrahim; William K Kaufmann
Journal:  Pigment Cell Melanoma Res       Date:  2015-11-03       Impact factor: 4.693

Review 2.  Roles of UVA radiation and DNA damage responses in melanoma pathogenesis.

Authors:  Aiman Q Khan; Jeffrey B Travers; Michael G Kemp
Journal:  Environ Mol Mutagen       Date:  2018-02-21       Impact factor: 3.216

3.  An Overview of Ultraviolet B Radiation-Induced Skin Cancer Chemoprevention by Silibinin.

Authors:  Rahul Kumar; Gagan Deep; Rajesh Agarwal
Journal:  Curr Pharmacol Rep       Date:  2015-06-01

4.  A comparative study of long interspersed element-1 protein immunoreactivity in cutaneous malignancies.

Authors:  Mohammad Ali Zolfaghari; Abbas Karimi; Elham Kalantari; Alireza Korourian; Alireza Ghanadan; Kambiz Kamyab; Nafiseh Esmaili; Amir Nader Emami Razavi; Zahra Madjd
Journal:  BMC Cancer       Date:  2020-06-17       Impact factor: 4.430

5.  RET Copy Number Alteration in Medullary Thyroid Cancer Is a Rare Event Correlated with RET Somatic Mutations and High Allelic Frequency.

Authors:  Teresa Ramone; Chiara Mulè; Raffaele Ciampi; Valeria Bottici; Virginia Cappagli; Alessandro Prete; Antonio Matrone; Paolo Piaggi; Liborio Torregrossa; Fulvio Basolo; Rossella Elisei; Cristina Romei
Journal:  Genes (Basel)       Date:  2020-12-29       Impact factor: 4.096

6.  Construction and validation of a prognostic risk model of angiogenesis factors in skin cutaneous melanoma.

Authors:  Songyun Zou; Yonggang Zhang; Limei Zhang; Dengchuan Wang; Shi Xu
Journal:  Aging (Albany NY)       Date:  2022-02-14       Impact factor: 5.682

7.  Comprehensive Gene Expression Analysis to Identify Differences and Similarities between Sex- and Stage-Stratified Melanoma Samples.

Authors:  Eirini Chrysanthou; Emir Sehovic; Paola Ostano; Giovanna Chiorino
Journal:  Cells       Date:  2022-03-24       Impact factor: 6.600

Review 8.  Evolving Therapeutic Strategies to Exploit Chromosome Instability in Cancer.

Authors:  Laura L Thompson; Lucile M-P Jeusset; Chloe C Lepage; Kirk J McManus
Journal:  Cancers (Basel)       Date:  2017-11-01       Impact factor: 6.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.